University of California San Francisco
Helen Diller Family Comprehensive Cancer Center

Spotlight: Eric J. Small, MD

Eric J. Small, MD

Eric J. Small, MD, serves holds the Doris and Donald Fisher Distinguished Professorship in Clinical Cancer Research; Stanford W. Ascherman and Norman R. Ascherman Endowed Chair, UCSF

The American Society of Clinical Oncology (ASCO) has named Eric J. Small, MD, to its Board of Directors. ASCO is the world’s preeminent organization of its kind, representing more than 40,000 oncology professionals around the globe.
 
Small, a professor of Medicine, is chief of the Division of Hematology/Oncology in the Department of Medicine at UCSF. His roles within the Helen Diller Family Comprehensive Cancer Center include serving as deputy director; and program leader for the Prostate Cancer Program. He holds the Doris and Donald Fisher Distinguished Professorship in Clinical Cancer Research; and the Stanford W. Ascherman and Norman R. Ascherman Endowed Chair at UCSF.
 
“ASCO has had a profound impact on my professional and career development. It has helped me frame the important scientific, medical and ethical perspectives that inform everything I do professionally. It has also provided me with a remarkable community, which despite its wonderful diversity, is steadfast in its commitment to improving the lives of patients with cancer,” Small said. “It is my hope that ASCO will continue to have this profound and formative impact on generations to come, despite the challenges that lie ahead. I hope I can contribute to this lasting legacy by serving on the ASCO board of directors.”
 
Small has held several volunteer and leadership positions since he joined ASCO in 1992, including associate editor of the Journal of Clinical Oncology; chair of the Molecular Markers Scientific Committee, the Scientific Program Committee, and the inaugural Prostate Cancer Symposium Steering and Program Committees; and a member of the ASCO Nominating Committee and the Conquer Cancer Foundation Grants Selection Committee. He was named a Fellow of ASCO (FASCO) in 2015.
 
ASCO's Board of Directors is comprised of oncology leaders who are elected to positions reflecting various specialties within the oncology field. Small begins a four-year term in June 2017.
 

See More Spotlights